A large proportion of CD4 T lymphocytes in AD patients contain chemokine receptor type 4 (CCR4) receptors, allowing them to bind to TH2-related chemokines such as thymus and activation-regulated chemokine (TARC) (13). The gene discussed is CCL17; the disease is Alzheimer disease.